Tutorials
Meridian Bioscience Inc logo

Meridian Bioscience Inc

$ 20.42 (0%) Aug 10
On watch
P/E:
33.23
P/B:
3.90
Market Cap:
$ 1.43B
Enterprise V:
$ 1.37B
Volume:
-
Avg Vol (2M):
-
Also Trade In:
Volume:
-
Market Cap $:
1.43B
PE Ratio:
33.23
Avg Vol (2-Month):
-
Enterprise Value $:
1.37B
PB Ratio:
3.90
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Meridian Bioscience Inc
NAICS : 325413 SIC : 2835
3471 River Hills Drive, Cincinnati, OH, USA, 45244
Description
Meridian Bioscience Inc is an integrated life science company. It develops and distributes diagnostic tests and reagents, as well as biologic substances used by pharmaceutical and biotechnology companies. Its Diagnostics segment manufactures tests primarily for gastrointestinal, viral, respiratory, & parasitic infectious diseases. Its testing platforms include isothermal DNA amplification, rapid immunoassays, and enzyme-linked immunoassays. The Life sciences segment sells b-antigens, antibodies, and reagents in bulk to other diagnostic manufacturers, the agriculture industry, and researchers. It also manufactures proteins that biopharmaceutical companies use in new drugs and vaccines. The entity has a business presence in the US and other countries.
Name Current Vs Industry Vs History
Cash-To-Debt 2.63
Equity-to-Asset 0.79
Debt-to-Equity 0.09
Debt-to-EBITDA 0.42
Interest Coverage 54.64
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 10.72
Distress
Grey
Safe
Beneish M-Score -2.72
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
12-1 Month Momentum % -1.19

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.52
Quick Ratio 2.36
Cash Ratio 1.38
Days Inventory 183.87
Days Sales Outstanding 51.9
Days Payable 36.45

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Dividend Growth Rate -100
3-Year Average Share Buyback Ratio -0.8

Financials (Next Earnings Date:2022-11-11 Est.)

LTS:0K0K's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 343.547
EPS (TTM) ($) 0.98
Beta 0
Volatility % 6.4
14-Day RSI 0
14-Day ATR ($) 0.000007
20-Day SMA ($) 20.422
12-1 Month Momentum % -1.19
52-Week Range ($) 19.592 - 20.668
Shares Outstanding (Mil) 43.75

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Meridian Bioscience Inc Filings

Document Form Filing Date
No Filing Data